Literature DB >> 22309675

Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.

Daniella D G Curi1, Angela Maggio Fonseca, José Antônio M Marcondes, José Alcione M Almeida, Vicente R Bagnoli, José Maria Soares, Edmund Chada Baracat.   

Abstract

OBJECTIVE: To compare the efficacy of metformin with that of lifestyle changes in patients with polycystic ovary syndrome (PCOS).
DESIGN: Prospective, randomized clinical trial of 40 women with PCOS to analyze the effects of metformin and lifestyle intervention treatments on menstrual pattern and hormone and metabolic profile. The duration of treatment was 6 months. Statistical analysis was done using Student's t-test.
RESULTS: Fifteen women in the metformin group and 12 in the lifestyle changes group completed the study. The menstrual pattern improved by ~67% in both groups. There was a significant decrease in waist circumference in the lifestyle changes group (101.8 ± 3.9 and 95.1 ± 3.6, at baseline and at 6 months of treatment, respectively; p < 0.001) and in body mass index (BMI) in both groups. The predictor of menstrual pattern improvement was BMI.
CONCLUSIONS: Both metformin and lifestyle changes may increase the number of menstrual cycles in PCOS. This effect was related to a decrease in BMI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309675     DOI: 10.3109/09513590.2011.583957

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  17 in total

Review 1.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Lara C Morley; Thomas Tang; Ephia Yasmin; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

2.  The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.

Authors:  Anran Wang; Tingting Mo; Qiao Li; Chuangpeng Shen; Min Liu
Journal:  Endocrine       Date:  2019-03-25       Impact factor: 3.633

Review 3.  Metformin in women with PCOS, cons.

Authors:  Marie L Misso; Helena J Teede
Journal:  Endocrine       Date:  2014-09-02       Impact factor: 3.633

4.  Lifestyle changes in women with polycystic ovary syndrome.

Authors:  Siew S Lim; Samantha K Hutchison; Emer Van Ryswyk; Robert J Norman; Helena J Teede; Lisa J Moran
Journal:  Cochrane Database Syst Rev       Date:  2019-03-28

5.  Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.

Authors:  Jia Yu; Caifei Ding; Zhoujia Hua; Xuejuan Jiang; Chenye Wang
Journal:  J Obstet Gynaecol Res       Date:  2021-03-11       Impact factor: 1.730

6.  Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis.

Authors:  Liza Haqq; James McFarlane; Gudrun Dieberg; Neil Smart
Journal:  Endocr Connect       Date:  2014-02-28       Impact factor: 3.335

Review 7.  Mental health and physical activity in women with polycystic ovary syndrome: a brief review.

Authors:  Francesca Conte; Lauren Banting; Helena J Teede; Nigel K Stepto
Journal:  Sports Med       Date:  2015-04       Impact factor: 11.136

8.  Nutritional and unhealthy behaviors in women with and without breast cancer.

Authors:  Maryam Ataollahi; Sedigheh Sedighi; Seyyedeh Zahra Masoumi
Journal:  Iran Red Crescent Med J       Date:  2014-09-05       Impact factor: 0.611

9.  Comparison of lifestyle in women with polycystic ovary syndrome and healthy women.

Authors:  Sedigheh Sedighi; Sedigheh Amir Ali Akbari; Maryam Afrakhteh; Taraneh Esteki; Hamid Alavi Majd; Zohreh Mahmoodi
Journal:  Glob J Health Sci       Date:  2014-08-31

Review 10.  Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Kaoutar Ennour-Idrissi; Elizabeth Maunsell; Caroline Diorio
Journal:  Breast Cancer Res       Date:  2015-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.